ZNF34
Zinc finger protein 34
Also known as: KOX32, ZNF34_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IZ26
- Gene
- ZNF34
- Ensembl
- ENSG00000196378
- Chromosome
- 8
- Canonical length
- 560 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Located in cytosol and nucleoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
560 residues, UniProt reviewed canonical sequence.
>Q8IZ26|ZNF34
1 MLLLLSDQLL LTALRKPNPQ AMAALFLSAP PQAEVTFEDV AVYLSREEWG RLGPAQRGLY
61 RDVMLETYGN LVSLGVGPAG PKPGVISQLE RGDEPWVLDV QGTSGKEHLR VNSPALGTRT
121 EYKELTSQET FGEEDPQGSE PVEACDHISK SEGSLEKLVE QRGPRAVTLT NGESSRESGG
181 NLRLLSRPVP DQRPHKCDIC EQSFEQRSYL NNHKRVHRSK KTNTVRNSGE IFSANLVVKE
241 DQKIPTGKKL HYCSYCGKTF RYSANLVKHQ RLHTEEKPYK CDECGKAFSQ SCEFINHRRM
301 HSGEIPYRCD ECGKTFTRRP NLMKHQRIHT GEKPYKCGEC GKHFSAYSSL IYHQRIHTGE
361 KPYKCNDCGK AFSDGSILIR HRRTHTGEKP FECKECGKGF TQSSNLIQHQ RIHTGEKPYK
421 CNECEKAFIQ KTKLVEHQRS HTGEKPYECN DCGKVFSQST HLIQHQRIHT GEKPYKCSEC
481 GKAFHNSSRL IHHQRLHHGE KPYRCSDCKK AFSQSTYLIQ HRRIHTGEKP YKCSECGKAF
541 RHSSNMCQHQ RIHLREDFSMLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZNF34 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.46
- Highest tissue expression
- 19 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 19 nTPM
- blood vessel: 15 nTPM
- retina: 12 nTPM
- ovary: 10 nTPM
- cervix: 9.9 nTPM
- colon: 9.6 nTPM
Single-cell type
- early primary spermatocytes: 33 nCPM
- breast myoepithelial cells: 23 nCPM
- rod photoreceptor cells: 18 nCPM
- late primary spermatocytes: 15 nCPM
- vascular smooth muscle cells: 15 nCPM
- pericytes: 15 nCPM
Immune cell
- non-classical monocyte: 16 nTPM
- eosinophil: 13 nTPM
- myeloid DC: 10 nTPM
- basophil: 8.3 nTPM
- memory CD8 T-cell: 7.8 nTPM
- naive B-cell: 7.5 nTPM
Brain region
- cerebellum: 19 nTPM
- white matter: 14 nTPM
- pons: 12 nTPM
- cerebral cortex: 12 nTPM
- hypothalamus: 12 nTPM
- basal ganglia: 12 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.72
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.21
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 13% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ZNF34 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZNF34 as an antibody target. Whether an autoantibody or antibody against ZNF34 could matter depends on whether native ZNF34 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZNF34 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZNF34 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...